Search
for
Sort by
Research 331–360 of 1000+
- Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection
- LC-ESI-QTOF-MS/MS Analysis, Cytotoxic, Antiviral, Antioxidant, and Enzyme Inhibitory Properties of Four Extracts of Geranium pyrenaicum Burm. f.: A Good Gift from the Natural Treasure
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Valproate Induced Hair Loss and Curly Hair in Bipolar Disorder
- In this Issue
- Serum paroxonase 1 level may be an indicator and predictor of the severity of androgenetic alopecia
- Intracrine androgen biosynthesis, metabolism and action revisited
- EtG Quantification in Hair and Different Reference Cut-Offs in Relation to Various Pathologies: A Scoping Review
- Sub-acute toxicity of standardized aqueous extract of Siddha herb Karisalankanni - Eclipta alba (L.) Hassk
- Photosensitization Outbreak in Shorthorn Calves in Missouri
- Protective Efficacy of Vitamin F against Acrylamide Induced Toxicity: Studies on Oxidative Stress Biomarkers
- Hair loss in athletic testosterone use in males: a narrative review
- Transcutaneous Auricular Vagus Nerve Stimulation Alleviates Monobenzone-Induced Vitiligo in Mice
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Editor's evaluation: Role of distinct fibroblast lineages and immune cells in dermal repair following UV radiation-induced tissue damage
- 66-Year-Old Woman With Painless Vesicular Lesions
- Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review
- Chemical Synthetic Disease Modifying Drugs (csDMARD) Used forRheumatoid Arthritis
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- Systematic Review: Adipose-Derived Mesenchymal Stem Cells, Platelet-Rich Plasma and Biomaterials as New Regenerative Strategies in Chronic Skin Wounds and Soft Tissue Defects
- TREM2 macrophages induced by human lipids drive inflammation in acne lesions
- Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?
- Protective Role of Melatonin and Its Metabolites in Skin Aging
- Role of β-Catenin Activation Levels and Fluctuations in Controlling Cell Fate
- Disrupted Pancreatic Exocrine Differentiation and Malabsorption in Response to Chronic Elevated Systemic Glucocorticoid
- Novel C-6 substituted and unsubstituted pregnane derivatives as 5α-reductase inhibitors and their effect on hamster flank organs diameter size
- Prevention of Male Late-Onset Hypogonadism by Natural Polyphenolic Antioxidants
- Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
- Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues
- Regulation of Epidermal Ferritin Expression Influences Systemic Iron Homeostasis